Pharma & Biotech •
•
7 min
Clinical Trial Failure Rates: What R&D Leaders Need to Know
Developing novel pharmaceutical therapeutics remains one of the highest-risk capital investments in global industry. Over 85% of clinical-stage molecules fail to achieve regulatory approval, with Phase II proof-of-concept trials accounting…
Mohan raj
Author